Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Mira Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −5 vs. Q4 2024
- Shares held
- 968.5K
- −153.5K (−13.7%) vs. Q4 2024
- Total value
- $949.1K
- −$329.7K (−25.8%) vs. Q4 2024
- New holders
- 3
- 4 more added
- Sold out
- 8
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $2.19M |
| Q1 2026 | 26 | $2.30M |
| Q4 2025 | 25 | $3.35M |
| Q3 2025 | 29 | $1.89M |
| Q2 2025 | 20 | $1.21M |
| Q1 2025 | 19 | $949.1K |
| Q4 2024 | 24 | $1.28M |
| Q3 2024 | 15 | $1.08M |
| Q2 2024 | 11 | $454.0K |
| Q1 2024 | 11 | $704.0K |
| Q4 2023 | 6 | $102.0K |
| Q3 2023 | 3 | $3.72K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Mira Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 16 | $16 | 0.00% | +16 | New |
| Steward Partners Investment Advisory, LLC | 1,000 | $980 | 0.00% | −2,700−73.0% | Reduced |
| Advisor Group Holdings, Inc. | 2,000 | $1.96K | 0.00% | 00.0% | Unchanged |
| Cary Street Partners Financial LLC | 10,000 | $9.80K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 10,103 | $9.90K | 0.00% | +40.0% | Added |
| Two Sigma Securities, LLC | 11,033 | $10.8K | 0.00% | −4,103−27.1% | Reduced |
| Mariner, LLC | 11,500 | $11.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 13,595 | $13.3K | 0.00% | −16,767−55.2% | Reduced |
| Jane Street Group, LLC | 14,772 | $14.5K | 0.00% | +14,772 | New |
| Praetorian Wealth Management, Inc. | 17,500 | $17.1K | 0.00% | 00.0% | Unchanged |
| First American Bank | 20,000 | $19.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 22,374 | $21.9K | 0.00% | −1,943−8.0% | Reduced |
| Commonwealth Equity Services, LLC | 25,547 | $25.0K | 0.00% | +10,475+69.5% | Added |
| J.W. Cole Advisors, Inc. | 40,000 | $39.2K | 0.00% | +40,000 | New |
| State Street Corp | 49,100 | $48.1K | 0.00% | 00.0% | Unchanged |
| Suncoast Equity Management | 103,289 | $101.2K | 0.01% | +80,645+356.1% | Added |
| Vanguard Group Inc | 117,824 | $115.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 135,418 | $132.7K | 0.00% | +13,332+10.9% | Added |
| Cross Staff Investments Inc | 363,401 | $356.1K | 0.27% | −2,500−0.7% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −97,976−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −63,410−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −45,772−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −27,993−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Transce3nd, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −6,901−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −160−100.0% | Sold out |